Catalog name Description price
R-Mcs-526 GO-PEG-Cy5.5-Dox complex Graphene Oxide PEG-Cy5.5-Dox complex is a multifunctional nano drug carrier system that combines graphene oxide (GO), polyethylene glycol (PEG), near-infrared fluorescent dye Cy5.5, and chemotherapy drug Doxorubicin (Dox), exhibiting synergistic advantages in tumor targeted therapy and real-time imaging. price>
R-Mcs-527 Targeted peptide DWRVIIPPRSA and rhodamine labeled polyester particles The DWRVIIPPRSA peptide segment is a short peptide with targeted properties that can recognize specific receptors or cell surface markers, while Rhodamine labeled polyester particles are commonly used for tracking and imaging studies. The combination of the two can be used to construct a targeted delivery real-time tracking integrated system, which has potential applications in biomedical research such as drug delivery, tumor imaging, or inflammation localization. price>
R-Mcs-535 Cy5.5 modified Fe-PCN-224@Au Cy5.5 modified Fe-PCN-224@Au/Cyanine5.5 modified Fe-PCN-224@Au/Cyanine5.5 modified Fe-PCN-224@GNPs/Cyanine5.5 modified Fe-PCN-224@gold nanoparticles is a multifunctional nanoprobe that integrates near-infrared fluorescence imaging, multimodal therapy, and targeted delivery. It is achieved by covalently or physically loading a lipid soluble Cy5.5 fluorescent dye onto the probe Fe-PCN-224@Au Composite material surface enables visual and precise diagnosis and treatment of tumors. price>
R-Mcs-536 Cy5.5-HA modified Fe-PCN-224@Au@LAT1-IN-1 Cy5.5-HA modified Fe-PCN-224@Au@LAT1-IN-1/Cy5.5-Hyaluronic acid modified Fe-PCN-224@Au@LAT1-IN-1 is an intelligent nanodiagnostic and therapeutic system that integrates active targeting, multimodal therapy, near-infrared fluorescence imaging, and metabolic intervention. It is designed specifically for high-precision tumor collaborative therapy and real-time monitoring. price>
R-Mcs-540 HSA@ICG-Bi2(SeO3)3 nanoparticles HSA@ICG-Bi2(SeO3)3 nanoparticles are multifunctional nanoparticles based on human serum albumin (HSA) encapsulating indocyanine green(ICG) and complexed with bismuth selenite (Bi2(SeO3)3).They combine the characteristics of biocompatible carriers,near-infrared fluorescence imaging,and inorganic functional materials,and have potential application value in the integration of tumor diagnosis and treatment. price>
R-Mcs-541 HSA@ICG nanoparticles ‌ HSA@ICG Nanoparticles/HSA encapsulated ICG nanoparticle are a diagnostic and therapeutic nanoplatform that integrates near-infrared fluorescence imaging and photothermal therapy.They are constructed using human serum albumin (HSA) as a carrier and indocyanine green (ICG) as a functional dye, and are widely used for precise diagnosis and synergistic therapy of tumors. price>
R-Mcs-544 FITC+targeting peptide Asp8 modified liposomes@DHA Ceramide FITC+targeting peptide Asp8 modified liposomes@DHA Ceramide/FITC and peptide Asp8 modified liposome loaded DHA Ceramide is an intelligent nano drug carrier system that integrates visual tracking, bone targeted delivery, and anti-tumor functions, suitable for targeted therapy and mechanism research of bone related diseases such as bone tumors and bone metastatic cancer. price>
R-M1-8762 LNP-cy5/RGD,100nm Liposome nanoparticles-cy5/RGD can be utilized in various applications, such as cancer imaging, targeted drug delivery, or theranostics (simultaneous diagnosis and therapy). price>
R-M1-8763 FITC-Ti3C2,200nm-1000nm FITC-Ti3C2/Fluorescein Isothiocyanate-Ti3C2 has the potential to be used for applications such as fluorescent labeling, bioimaging, drug delivery, or biosensing, where the fluorescence of FITC can be employed for visualization purposes, while the TI3C2 nanoparticles contribute their desirable properties for specific functionalities or carrier capabilities. price>
R-M1-cs8773 CY7@EScu@ROSlnp-YSAYPDSVPMMS ROS responsive liposome nanoparticles encapsulate ESCU and CY7 surface modified peptides,CY7@EScu@ROSlnp-YSAYPDSVPMMS from ruixi.This system combines the benefits of ROS-responsive liposome nanoparticles with the specific properties of ESCU and CY7 surface-modified peptides, potentially enabling targeted drug delivery or imaging in ROS-rich environments. price>